LY041001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LY041001, covering 2020-05-20 to 2020-05-20. Get the full timeline:
Most recent: Clinical Trial Update: An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus [Phase 3]